MedTrace Logo

Barrier Enhancement for Eczema Prevention

NCT04680520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1394

Last updated 2022-11-28

No results posted yet for this study

Summary

The primary objective is to determine whether advising parents to apply emollient (moisturiser) to their child's skin for the first year of life in addition to best practice infant skin care advice can prevent or delay the onset of eczema in high-risk children, when compared with a control group who are given the best practice infant skin care advice only.

Conditions

Interventions

OTHER

Experimental (Doublebase Gel® or Diprobase Cream®)

Emollient (Doublebase Gel® or Diprobase Cream®) use on the skin. The emollient should be applied at least once a day.

OTHER

Best practice skin care advice booklet

This is a booklet containing advice on best practice skin care. This will contain information on avoiding soap etc.

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Hywel Williams · Centre of Evidence-Based Dermatology, University of Nottingham.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
21 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2018-12-01
Completion
2022-01-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04680520 on ClinicalTrials.gov